Lipella Pharmaceuticals
LIPO
#10024
Rank
A$4.5 M
Marketcap
$3.73
Share price
-1.63%
Change (1 day)
-73.43%
Change (1 year)

P/E ratio for Lipella Pharmaceuticals (LIPO)

P/E ratio as of November 2024 (TTM): -3.74

According to Lipella Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.73672. At the end of 2022 the company had a P/E ratio of -6.92.

P/E ratio history for Lipella Pharmaceuticals from 2022 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-6.92

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.